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Loss of Hippocampal Serine Protease BSP1/Neuropsin Predisposes
to Global Seizure Activity
Ben Davies,1 Ian R. Kearns,2 Jan Ure,1 Ceri H. Davies,2 and Richard Lathe1
1Center for Genome Research and 2Department of Neuroscience, Center for Neuroscience, University of Edinburgh,
Edinburgh EH9 3JQ, United Kingdom
Serine proteases in the adult CNS contribute both to activity-
dependent structural changes accompanying learning and to
the regulation of excitotoxic cell death. Brain serine protease 1
(BSP1)/neuropsin is a trypsin-like serine protease exclusively
expressed, within the CNS, in the hippocampus and associated
limbic structures. To explore the role of this enzyme, we have
used gene targeting to disrupt this gene in mice. Mutant mice
were viable and overtly normal; they displayed normal hip-
pocampal long-term synaptic potentiation (LTP) and exhibited
no deficits in spatial navigation (water maze). Nevertheless,
electrophysiological studies revealed that the hippocampus of
mice lacking this specifically expressed protease possessed an
increased susceptibility for hyperexcitability (polyspiking) in re-
sponse to repetitive afferent stimulation. Furthermore, seizure
activity on kainic acid administration was markedly increased in
mutant mice and was accompanied by heightened immediate
early gene (c-fos) expression throughout the brain. In view of
the regional selectivity of BSP1/neuropsin brain expression, the
observed phenotype may selectively reflect limbic function,
further implicating the hippocampus and amygdala in control-
ling cortical activation. Within the hippocampus, our data sug-
gest that BSP1/neuropsin, unlike other serine proteases, has
little effect on physiological synaptic remodeling and instead
plays a role in limiting neuronal hyperexcitability induced by
epileptogenic insult.
Key words: brain serine protease; BSP1; cortex; epileptiform;
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Serine proteases fulfil diverse roles in the CNS. During develop-
ment, they contribute to the dynamic rearrangement of the ex-
tracellular matrix, whereas, in the adult, their roles extend to (1)
activating and processing neuropeptides, growth hormones, and
neurotrophic factors, (2) structural plasticity associated with
learning and memory processes, and (3) regulating neuronal
survival and proliferation. This protease family has also been
implicated in the pathophysiology of neurodegenerative disorders
including Alzheimer’s disease (Selkoe, 1991).
At the synaptic level, controlled proteolysis contributes to
developmental remodeling of neuronal contacts and to memory
consolidation (Bailey and Kandel, 1993). Specifically, tissue-type
plasminogen activator (t-PA) has been suggested to play a pivotal
role. t-PA contributes to developmental synaptogenesis (Vassalli
et al., 1991) and is implicated in synaptic correlates of learning
including long-term potentiation (LTP) (Frey et al., 1996; Huang
et al., 1996; Baranes et al., 1998; Madani et al., 1999; Calabresi et
al., 2000). Activity-dependent upregulation of t-PA production
(Qian et al., 1993; Gualandris et al., 1996) may lead to plasmin-
ogen activation and proteolysis of the extracellular matrix (Chen
and Strickland, 1997), thereby shaping long-lasting synaptic
changes (Nakagami et al., 2000).
Serine proteases also regulate excitotoxic neuronal cell death.
Mutant mice lacking t-PA, or plasminogen, are resistant to sei-
zure induction and neuronal cell death after kainic acid injection
(Tsirka et al., 1995, 1997). However, the role serine proteases
fulfill in neurodegeneration is complex, and t-PA has also been
reported to be neuroprotective (Vandenberghe et al., 1998; Kim
et al., 1999). Such potentially paradoxical findings suggest com-
plex regulation of neurodegeneration by serine proteases. This is
indicated by studies on the serine protease inhibitor PN-1 in
which either overexpression or loss increased sensitivity to exci-
totoxic cell death (Lu¨thi et al., 1997). These studies suggest that
a delicate balance of proteolysis is required within the adult brain
to maintain normal function; perturbations in this equilibrium
can have profound effects on neuronal survival.
Perhaps reflecting this complex regulation, diverse members of
the serine protease family are expressed in the CNS, notably in
the hippocampus. In a systematic survey of family members ex-
pressed within this formation, we identified a novel trypsin-like
protease, brain serine protease 1 (BSP1), that was strikingly
restricted to the rat hippocampal CA1 and CA3 subfields, with
some expression in adjacent entorhinal cortex (Davies et al.,
1998). The mouse ortholog neuropsin is also prominently ex-
pressed in the hippocampus, although expression was also de-
tected in the amygdala and other limbic structures (Chen et al.,
1995). Outside the CNS, neuropsin levels are high in the skin,
particularly during embryogenesis, and at lower levels in a variety
of other organs throughout development (Chen et al., 1998).
The abundance and restricted expression of brain BSP1/
neuropsin in the hippocampus and associated brain regions
suggest that BSP1/neuropsin may play a role in shaping neu-
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ronal excitability associated with neurodegenerative and mne-
monic processes. To explore this possibility, we have developed
mutant mice in which the BSP1/neuropsin gene has been
disrupted. Homozygous mutant mice display an unusual phe-
notype, perhaps indicating that BSP1/neuropsin plays a spe-
cialized role in regulating hippocampal function in response to
insult.
MATERIALS AND METHODS
Gene targeting in embryonic stem cells. Regions of the BSP1/neuropsin
gene 5 and 3 of exon III were amplified from genomic DNA obtained
from the embryonic day 14 (E14)-TG2a embryonic stem (ES) cell line
using the Expand Long Range PCR system (Roche Products, Welwyn
Garden City, UK). A 1.2 kb 5 homology arm, encompassing exons I and
II and the first and second introns, was amplified using primers 5-
dTGGTCGACCCCTAGCTCCATCCTCCAGCAAGACT-3 and 5-
dTGGTCGACCTGGAGGCTATGATCACCCAGACGCA-3 corre-
sponding to nucleotides 354–380 and 728–853 of the published mouse
neuropsin cDNA sequence [accession number D30785; as revised from
Chen et al. (1995)], respectively. A 4.5 kb 3 homology arm, correspond-
ing to the third and fourth intron and exons IV and V, was amplified
using primers 5-dGAGCGGCCGCATCATATCAGGCTGGGGCAC-
TGT-3 and 5-dGAGTCGACAGCATCCCGTCGCACACCAGA-3
corresponding to nucleotides 941–964 and 1130–1151 of the above se-
quence, respectively. The PCR conditions recommended by the supplier
were used with an annealing temperature of 62°C and an elongation time
of 5 min with a 20 sec/cycle increment for both sets of primers. Homol-
ogy arms were subcloned into pBluescript KS around a 5 kb reporter/
selection cassette, comprising the lacZ reporter coding sequence prefixed
by a viral IRES element and also containing a neomycin phosphotrans-
ferase gene under independent promoter control (MC1) and a polyade-
nylation sequence (Nehls et al., 1996) (see Fig. 1). The hybrid construct
was suffixed by two copies of a herpes simplex virus thymidine kinase
expression cassette (Smith et al., 1995) and transfected into E14-TG2a
ES cells. Junction regions of the construct were confirmed by sequencing.
Positive–negative selection (Mansour et al., 1988) was used to enrich for
targeted clones. Colonies were screened by restriction enzyme digestion
(EcoRV; HindIII) and by Southern blot hybridization to separate probes
localized immediately 5 and 3 of the homology arms (see Fig. 1); the 5
and 3 probes were also PCR amplified from genomic DNA using primers
5-dCCCGCCCCTTGCATTCTGGAAGGT-3and 5-dAGTCTTGCT-
GGAGGATGGAGCTA-3 (corresponding to nucleotides 50–73 and
356–379 of the neuropsin cDNA sequence, respectively) and 5-
dCCTCTGGTGTGCGACGGGATGCTCCA-3 and 5-dCGAGATC-
TCGAGTCCCTGTTGTCCATGGTCTTCTTGA-3 (corresponding to
nucleotides 1129–1154 and 1241–1268 of the neuropsin cDNA sequence,
respectively). The 5 probe recognized a 3.1 kb wild-type EcoRV frag-
ment and a 1.8 kb targeted allele, whereas the 3 probe recognized a 12
kb wild-type HindIII fragment and a 14 kb targeted allele.
Generation of transgenic mice. Targeted ES cell clones were injected
into the blastocysts of strain C57BL/6 mice; chimeric males were mated
to strain C57BL/6 females; typing of transgenic progeny was performed
by Southern blotting using the probes described above or by PCR analysis
of tail-tip DNA using an upstream primer hybridizing to exon II (5-
dCGGAATTCCGACTGATCTGTGGGGGTGTCCTGGTTG-3, cor-
responding to nucleotides 651–676 of the mouse neuropsin cDNA) and
two downstream primers, one hybridizing to the 5 end of the knocked-in
reporter/selection cassette (5-dCCCGGGATCATATCAGGCTGG-
GGCACTG-3) and the other hybridizing to a region of exon III deleted
in the knock-out allele (5-GACAGTGCCCCAGCCTGATATGATG-
3, corresponding to nucleotides 962–966 of the mouse cDNA sequence).
By the use of these primers, a 650 bp band was amplified from the
wild-type allele, and a 450 bp band was amplified from the transgenic
allele, permitting both genotypes to be determined with a single PCR
reaction (30 cycles at 94°C, 60 sec; 60°C, 60 sec; and 72°C, 45 sec). Mice
were systematically backcrossed against C57BL/6 animals. To prepare
homozygotes, littermates were intercrossed for each experiment.
Electrophysiology. In accordance with United Kingdom Home Office
guidelines, mice were killed, and brains were dissected and placed in
ice-cold artificial CSF (aCSF, 124 mM NaCl, 3 mM KCl, 1 mM MgSO4,
1.25 mM NaH2PO4, 26 mM NaH2CO3, 2 mM CaCl2, and 10 mM
D-glucose) saturated with 95% CO2–5% O2. Transverse hippocampal
slices (350 m) were prepared using a Campden vibroslicer and imme-
diately transferred to a submersion-type chamber at 32°C. Extracellular
field potential responses were recorded using thin-walled glass microelec-
trodes (1–5 M) filled with 4 M NaCl or aCSF placed in the stratum
radiatum or stratum pyramidale in area CA1 of the hippocampus. Re-
producible EPSPs or population spikes were evoked by repetitive afferent
stimulation (0.067 Hz) in stratum radiatum using bipolar nickel–chro-
mium electrodes. Late-phase LTP was induced by a series of four tetani
each comprising 100 Hz for 1 sec delivered 5 min apart. Paired-pulse
stimulation and 1 Hz trains were generated using a Master 8 stimulator.
Statistical analyses were performed on raw data using ANOVA.
Behavioral studies. Testing was performed in an open field water maze
(diameter, 2 m) filled with opaque water (25 1°C) surrounded by visual
cues with a submerged platform (diameter, 20 cm). Swim paths were
monitored with an overhead video camera connected to an image ana-
lyzer (HVS Image, Hampton, UK) and an Acorn (Framlingham, UK)
computer, running software that sampled coordinates on-line at 10 Hz
for subsequent automated data analysis. Mice were trained for two
periods of 4 d with 4 trials/d (10 min intertest interval; maximum trial
time of 120 sec, after which mice were guided to the platform). On day
5 the platform was removed, transfer tests of 60 sec were performed, and
the time spent in each quadrant was measured. BSP1/neuropsin knock-
out and wild-type littermate controls (n  8; n  8) were coded; all
experiments were performed blind.
Seizure studies. Kainic acid (Sigma, Poole, UK) in PBS was adminis-
tered intraperitoneally at two doses (15 mg/kg; n  8, n  8; and 30
mg/kg; n  8, n  10) to BSP1/neuropsin knock-out and wild-type
littermates. Mice were monitored for a period of 2–3 hr after the
injection. Baseline parameters were established with mice of each geno-
type injected with intraperitoneal PBS. In parallel, mice receiving 15
mg/kg were killed at 2 and 48 hr after the challenge for histological
analysis. Mice receiving 30 mg/kg were killed at 30, 90, 120, and 240 min
after the challenge.
In situ hybridization. A 370 bp region of the c-fos cDNA was amplified
from brain cDNA using primers 5-dCGGAGGAGGGAGCTG-
ACAGATACACT-3 and 5-dGCCTAGATGATGCCGGAAACAAG-
AA-3 and cloned into pBluescript (Stratagene, La Jolla, CA). Frozen
tissue sections (10 m) were transferred to 2-aminopropyltriethoxysilane-
coated slides [4% (w/v) paraformaldehyde, 15 min; 4°C], deproteinized (20
g/ml proteinase K, 1 min; block with 0.2% glycine, 5 min), acetylated
[0.25% acetic anhydride, 0.1 M triethanolamine, pH 8, and 0.8% (w/v)
NaCl, 10 min], dehydrated by passing through successively increasing
ethanol solutions (50–100% ethanol), immersed in CHCl3, rinsed in etha-
nol, and air-dried. For hybridization, sections were incubated overnight at
55°C with 35S-riboprobes (prepared by in vitro transcription from pBlue-
script and pretreated with 10 mM dithiothreitol) in buffer containing 50%
(v/v) deionized formamide, 0.3 M NaCl, 20 mM Tris-Cl, pH 8, 5 mM EDTA,
10 mM NaPO4, pH 8, 10% (w/v) dextran sulfate, 1 Denhardt’s solution,
and 0.5 mg/ml yeast RNA. High-stringency washing (2 SSC and 0.1 M
dithiothreitol; 65°C; 30 min) was followed by RNase treatment (RNase A;
20 g/ml; 30 min; 37°C), washing, and dehydration through increasing
ethanol concentrations. Slides were exposed for autoradiography (Kodak
Biomax).
RESULTS
Disruption of the mouse BSP1/neuropsin gene
To address the role of the BSP1/neuropsin protease in hippocam-
pal function, the gene encoding this enzyme was inactivated by
homologous recombination in mouse ES cells. A region of exon
III encoding the aspartic acid region of the catalytic site was
deleted and replaced with a neomycin resistance gene, a
-galactosidase reporter gene, and translation termination codons
in all three reading frames (Fig. 1A). The disruption of the
BSP1/neuropsin gene was confirmed by genomic Southern blot
analysis (Fig. 1B).
The insertion harbored a lacZ reporter cassette prefixed by an
IRES element; chromogenic activity in heterozygous animals was
used as a marker of the expression pattern of BSP1/neuropsin
mRNA. However, analysis of whole brain revealed no significant
staining in the hippocampus or any other brain regions. Further-
more, lacZ mRNA was not detected in the brains of heterozygous
mice by in situ hybridization techniques (data not shown), sug-
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gesting that the BSP1–IRES–lacZ fusion downregulates or de-
stabilizes the hybrid transcript. However, in skin, in which signif-
icant BSP1/neuropsin expression has been recorded previously
(Chen et al., 1998), lacZ mRNA and reporter activity were readily
detected in tissue from heterozygous animals but not from wild-
type littermate controls (data not shown).
Heterozygote intercrosses produced animals homozygous for
the gene disruption. Northern blot analysis of brain mRNA
confirmed the absence of BSP1/neuropsin transcripts in mutant
animals (Fig. 1C). Homozygous animals were born at the ex-
pected Mendelian ratio and displayed no obvious health, growth,
or fertility abnormalities. Furthermore, despite the reported
expression of BSP1/neuropsin during development, histologi-
cal analysis of adult hippocampus as well as other brain regions
failed to demonstrate any obvious changes in histoarchitecture
(Fig. 1 D).
Long-term potentiation is unaltered in BSP1/neuropsin
mutant mice
In the absence of any overt phenotype, we inspected neuronal
function in the mutant mice in more detail. Serine proteases have
been implicated in late-phase LTP, perhaps by facilitating struc-
tural changes at the synapse that contribute to the longevity of
potentiation. BSP1/neuropsin expression is most prominent in the
hippocampus; accordingly we analyzed slices prepared from
BSP1/neuropsin knock-out mice and wild-type littermate controls
for the extent of CA1 LTP induced by four consecutive tetani
(each comprising 100 Hz for 1 sec) delivered 5 min apart. Base-
line recordings revealed the absence of any gross modification of
glutamatergic synaptic transmission (below) and the resting mem-
brane potential; cell input resistance and spike frequency adap-
tation of CA1 pyramidal neurons were unchanged by BSP1 dele-
tion (data not shown). Furthermore, no significant differences in
the magnitude or profile of LTP induced in hippocampal slices
prepared from each group of animals were observed at any time
point after tetanization ( p  0.05), although there was an appar-
ent trend for elevated LTP in BSP1/neuropsin knock-out slices
(Fig. 2). The slope of the potentiated field EPSP (fEPSP) mea-
sured 4 hr after tetanization in BSP1/neuropsin knock-out slices
was 167 15% of control (n 7), whereas that in wild-type slices
was 136  15% of control (n  7).
BSP1/neuropsin mutant animals perform normally in
the water maze
The absence of a clear change in LTP in BSP1/neuropsin knock-
out animals does not exclude the possibility that this serine
protease might affect learning and/or memory processes in vivo.
To examine this we compared the performance of wild-type and
BSP1/neuropsin mutant animals in the water maze spatial refer-
ence memory task (Morris et al., 1982). Animals placed in a
2-m-diameter pool were required to learn the location of a sub-
merged platform using visual cues outside the maze. Learning
Figure 1. Targeted disruption of the murine BSP1/neuropsin locus. A,
Structure of the targeting vector (top), wild-type BSP1/neuropsin allele
(middle), and targeted allele (bottom) showing deletion of the catalytic
aspartic acid residue region of exon III; asterisks indicate active site
residues. A selection cassette (MC1–neo–pA), conferring resistance to
G418 and a reporter cassette (IRES–lacZ–pA) allowing dicistronic trans-
lation of the bacterial -galactosidase gene from the targeted allele were
inserted. Two copies of a herpes simplex virus thymidine kinase gene
(MC1–tk) were included in the vector for selection against nonhomolo-
gous integration. BSP1/neuropsin coding regions are indicated by filled
boxes; the position of EcoRV (E) and HindIII (H) restriction sites and the
probe used for the 5 targeting screen are shown. B, Southern blot analysis
of tail genomic DNA from wild-type (/), heterozygous (/), and
homozygous knock-out (/) animals demonstrating disruption of the
BPS1/neuropsin gene. The probe hybridizes to a 3.1 kb EcoRV wild-type
fragment and a 1.8 kb EcoRV fragment from the targeted allele. C, Top,
Northern blot analysis of total RNA of the hippocampus (Hi) and rest of
the brain (R) from BSP1/neuropsin mutant animals (/) and wild-type
littermates (/) hybridized with the BSP1/neuropsin cDNA. Bottom,
The same blot hybridized with S26 ribosomal protein cDNA demonstrat-
ing equal loading of the blot. D, Photomicrograph of cresyl violet-stained
horizontal sections through the hippocampus and entorhinal cortex of
wild-type (/; lef t) and BSP1/neuropsin mutant (/; right) animals.
Figure 2. LTP in BSP1/neuropsin mutant and control mice. Graph
showing the field EPSP slope expressed as a percentage of control
responses over time. All data points represent 5–10 averaged fEPSPs;
error bars indicate SEM. At time 0, four trains of stimulation (100 shocks
at 100 Hz; interstimulus interval, 5 min) were delivered to the Schaffer
collateral–commissural pathway. Closed circles represent pooled data
from wild-type control mice, and open circles represent BSP1/neuropsin
mutant pooled data. Insets, Synaptic traces representing two superimposed
field EPSPs recorded in the stratum radiatum of area CA1 in response to
single-shock stimulation in the same dendritic field immediately before
tetanic stimulation and 3 hr after conditioning in hippocampal slices taken
from wild-type (lef t) and BSP1/neuropsin / (right) mice.
Davies et al. • Brain Serine Protease 1/Neuropsin Mutant Mice J. Neurosci., September 15, 2001, 21(18):6993–7000 6995
occurred over the first and second 4 d periods of training in both
mutant and wild-type groups. No significant differences in escape
latency were observed (Fig. 3A). After 4 d of training, the plat-
forms were removed; animals were examined for any learned
preference for the quadrant in which the platform had been
located previously. A spatial bias developed for the trained quad-
rant in all animals; no significant differences in the performance
of wild-type and mutant groups were observed (Fig. 3B).
Increased polyspiking in slices from
BSP1/neuropsin-deficient mice
Serine proteases are implicated in regulating the balance between
synaptic excitation and inhibition; such changes may not neces-
sarily relate to effects on LTP. Despite the lack of obvious
changes in LTP and spatial reference memory, we therefore
investigated the excitability of hippocampal slices from mutant
and wild-type animals during repetitive stimulation that induces
transient activity-dependent alterations in transmembrane ionic
gradients (e.g., K) and both glutamatergic and GABAergic
(both GABAA and GABAB receptor-mediated) synaptic
strength. In particular, the potential for hippocampal slices to
exhibit polyspike discharges (EPSPs generating multiple popula-
tion spikes) in response to 1 Hz stimulation for 30 sec was
investigated.
Irrespective of the genotype of the slice, repetitive stimulation
(30 shocks at 1 Hz) of the Schaffer collateral–commissural path-
way induced polyspiking. However, throughout the period of
afferent stimulation, it was apparent that in slices prepared from
the BSP1/neuropsin mutant animals the extent of polyspiking was
significantly greater than that in littermate wild-type control slices
(knock-out, n  5; wild-type, n  9; p 	 0.05; Fig. 4).
Potentially, changes in baseline excitability could explain this
observation. However, the input–output relationships for fEPSPs
in wild-type (n  6) and BSP1/neuropsin / (n  9) slices were
indistinguishable, as illustrated by the comparison of the ratio of
the presynaptic fiber volley size with fEPSP amplitude plotted in
Figure 5A. Equally, the population spikes recorded in wild-type
(n  6) and BSP1/neuropsin knock-out (n  6) hippocampi
revealed no genotype-dependent differences in the peak ampli-
tude of the maximal achievable population spike (Fig. 5B).
These observations suggest that the increase in excitability to
sustained 1 Hz stimulation seen in slices from BSP1/neuropsin
/ mice is an activity-dependent phenomenon. We therefore
examined whether this might relate to changes in paired-pulse
facilitation that provides the simplest model for activity-
dependent changes. As expected, paired stimulation within the
stratum radiatum over a range of interpulse intervals (from 15 to
Figure 3. Spatial reference memory in BSP1/neuropsin mutant and con-
trol mice. A, Graph showing the mean latency of escape of BSP1/neurop-
sin mutant mice (open circles; n  8) and wild-type littermate controls
(closed circles; n  8) against trial day. Both groups show a significant
interaction between latency and trial day, indicating learning (ANOVA,
p 	 0.05). No significant interaction between latency and genotype was
found (ANOVA, p  0.05). B, Results of the second transfer test showing
the average percentage of time spent in the training quadrant (Train) and
the adjacent right (Adj/R), adjacent left (Adj/L), and opposite (Opp)
quadrants for BSP1/neuropsin mutant animals (open vertical bar) and
wild-type littermate controls (solid vertical bar). A pronounced preference
for the training quadrant is demonstrated in both groups (ANOVA, p 	
0.05) but with no significant difference between genotypes (ANOVA, p 
0.05).
Figure 4. Polyspiking in slices from BSP1/neuropsin-deficient mice. A,
Example of population spikes evoked by stimulation of the Schaffer
collaterals recorded in the stratum pyramidale of the CA1 in BSP1/
neuropsin knock-out mice (/; bottom) and wild-type littermate con-
trols (/; top). Traces shown are before and immediately after repetitive
stimulation (1 Hz; 30 sec). Increased polyspiking (i.e., multiple population
spikes) in the BSP1/neuropsin knock-out mice is shown by arrows. Arrow-
heads, time of afferent stimulation. B, Time course of the appearance of
polyspikes during repetitive stimulation (amplitude of the second spike
expressed as a percentage of the first population spike) in slices from
BSP1/neuropsin knock-out mice (open circles; n  5) and from wild-type
littermate controls (closed circles; n 9). A significant increase ( p	 0.05)
in the extent of polyspiking was found in BSP1/neuropsin knock-out mice.
There were no significant differences in other measures of neuronal
excitability in wild-type (WT) and BSP1 mutant (M) mice (this figure;
Fig. 5); these parameters were the following (n  6 in each case): resting
membrane potential (WT, 68  3 mV; M, 65  2 mV), cell input
resistance (WT, 73  10 M; M, 68  16 M), and spike frequency
adaptation measured in terms of the number of action potentials fired in
response to a 0.4 nA, 1 sec current step delivered at the resting
membrane potential of the neuron (WT, 8  2; M, 7  2).
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300 msec) induced paired-pulse facilitation of glutamate-
mediated fEPSPs in both wild-type and BSP1/neuropsin knock-
out animals. Whereas the magnitude of this facilitation was not
significantly different between the two groups ( p 0.05; Fig. 5C),
BSP1/neuropsin mutant animals showed a clear trend toward
increased facilitation at all interval ranges, although the extent of
the observed increase was much smaller than that induced by the
1 Hz polyspiking train.
Heightened seizure activity on kainate challenge of
BSP1/neuropsin mutant mice
These in vitro data raised the possibility that, during periods of
increased neuronal activity, BSP1/neuropsin knock-out animals
might display heightened excitability, thus predisposing them to
epileptogenesis. To address this, we studied the ability of the
glutamate receptor agonist kainic acid to induce convulsions in
mutant and control mice. Two (intraperitoneal) doses were
tested, and animals were monitored for physiological and behav-
ioral changes. Brain histological analysis was performed in
parallel.
At the lower dose (15 mg/kg), all animals irrespective of
genotype or sex exhibited a similar temporal profile of physiolog-
ical seizure activity in response to drug challenge, with onset of
seizure activity at 
20 min after insult in both genotypes. In
tissue sections taken at 2 d after the challenge, histological anal-
ysis showed no overt evidence of neuronal cell death in either
wild-type or mutant mice. In the absence of cell death, the effects
of neuronal excitation can be followed by monitoring the expres-
sion of immediate early genes such as the transcription factor
c-fos. The spatiotemporal pattern of c-fos induction has been well
characterized after kainic acid treatment (La Gal La Salle, 1988;
Popovici et al., 1990), and high levels of expression correlate well
with susceptibility to cell death in this pharmacological model
(Smeyne et al., 1993). Despite the absence of overt cell death,
sections taken at 2 hr after the challenge revealed marked induc-
tion of c-fos expression in both wild-type and knock-out mice.
Interestingly, at this time point, expression levels were markedly
increased in BSP1/neuropsin mutant animals in comparison with
wild-type littermates (Fig. 6A).
These preliminary results indicated that responsiveness to
kainic acid might be enhanced in BSP1/neuropsin mutant ani-
mals. This prompted us to monitor the effects of a higher dose (30
mg/kg) of kainic acid and to investigate in more detail immediate
early gene expression changes. After intraperitoneal injection,
seizures were again recorded in both wild-type and BSP1/
neuropsin mutant animals, and with a similar latency of onset.
Both wild-type and mutant animals displayed motion arrest at the
same time after the challenge (wild type, 22.42  1.36 min;
mutant, 21.33  1.84 min; Students t test, p  0.05), followed by
contemporaneous onset of head and neck muscular myoclonus
after the challenge (wild type, 38.33  3.65 min; mutant, 34.40 
3.42 min; Students t test, p  0.05). However, the later profile of
seizure response was clearly different between the two genotypes.
In wild-type animals, mild seizures developed into whole-body
convulsions in all animals (40–60 min after the challenge) with
the majority of wild-type animals (8/10) continuing to display
bouts of tonic–clonic seizure for a further 60 min before normal
behavior resumed. In contrast, a subsequent extreme tonic–clonic
phase was observed in the majority (7/8) of BSP1/neuropsin
mutant mice. This was characterized by rigidity and limb exten-
sion and was quickly followed by death (Fig. 6B). In situ hybrid-
ization analysis on postmortem sections revealed that all seizure
phases were accompanied by elevated c-fos gene expression; as in
the lower dose experiment, this was more widespread and intense
in mutant animals than in controls (Fig. 6C).
DISCUSSION
To explore the function of BSP1/neuropsin, we have investigated
the consequences of abolition of its activity in vivo. Because
pharmacological agents that selectively interfere with BSP1/
neuropsin activity are not presently available, we used a trans-
genic approach. Analysis of mice containing an engineered dis-
ruption of the gene encoding the serine protease BSP1 (also
known as neuropsin) suggests a role for this protease in regulat-
ing neuronal excitability within the limbic system. Although pat-
terns of neuronal excitability during embryonic and early postna-
tal development are believed to be critical for correct wiring of
the CNS, BSP1/neuropsin mutant animals were born at the ex-
pected Mendelian ratio and displayed no obvious neuroanatomi-
cal abnormalities. Gene disruption also failed to affect either
Figure 5. Baseline synaptic transmission in BSP1/neuropsin mutant an-
imals. A, Peak-evoked fEPSP amplitudes in response to single-shock
stimulation. Amplitudes over a range of stimulus intensities are plotted
against the peak amplitudes of the presynaptic fiber volleys (PSFV )
immediately preceding the fEPSPs for both wild-type and BSP1/neurop-
sin / slices (n  8 for each genotype). B, Left, Population spikes in
wild-type (top) and BSP1/neuropsin / (bottom) slices. Right, Graph
depicting the pooled maximum peak amplitude of these responses sam-
pled (n  6 in each case) from wild-type and BSP1 / animals. C, Left,
Synaptic traces showing fEPSPs recorded in response to paired-pulse
stimulation delivered at an interstimulus interval of 25 msec in control
(top) or BSP1/neuropsin / (bottom) slices. Right, Graph recording the
magnitude and temporal profile of paired-pulse facilitation (calculated as
the slope of the second fEPSP divided by the slope of the first EPSP) in
wild-type and BSP1/ slices (n  8 for each genotype).
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hippocampal LTP or spatial navigation in the water maze. How-
ever, BSP1/neuropsin mutant hippocampus exhibited a pro-
nounced predisposition to polyspiking during periods of repeti-
tive afferent activity in vitro, and kainic acid challenge in vivo
provoked heightened seizure activity that was accompanied by
elevated immediate early gene expression throughout the brain
and physiological seizure intolerance.
Transgenic studies of seizure
The results of transgenic studies are often qualified because of the
potential role of genetic background in shaping phenotypes. The
mouse study group used in our experiments was of C57BL/6 
129 mixed genetic background, of note because C57BL/6 mice
learn better and are slightly more resistant to kainic acid excito-
toxicity than are other strains of mice, e.g., 129 (Schauwecker and
Steward, 1997; Royle et al., 1999). In our experiments genetic
background influences were minimized by using both wild-type
and mutant (/) animals of a similar C57BL/6  129 hybrid
background [with the exception of genes linked to the BSP1/
neuropsin gene disruption (Gerlai, 1996)]. Although we cannot
wholly exclude stochastic allelic reassortment and/or allelic vari-
ations at a linked locus as contributing factors to the observed
phenotype, our results parallel those of several other groups
demonstrating a role for serine proteases in the regulation of
neuronal activity (Tsirka et al., 1995, 1997; Lu¨thi et al., 1997).
We have also been concerned that the heightened seizure
activity we observe in vivo might be a consequence of alterations
in uptake or metabolism of the inducer kainic acid. However,
there was no detectable difference in the time of seizure onset
between knock-out and control animals. Early phase signs, for
instance, the severity of head and neck muscular myoclonus, were
indistinguishable between the two groups. This suggests that
there is no difference in the rate of uptake of kainate into the
brain between mutant animals and controls. Furthermore, the in
vitro correlate of epileptiform activity (polyspiking) was seen in
the absence of an inducer.
Heightened seizure activity in BSP1/neuropsin knock-out ani-
mals is reproduced in many other transgenic models (Frankel,
1999), suggesting that seizure threshold is subject to multiple
levels of regulation that together maintain a delicate balance.
Notably, 200 genetic loci have been implicated in hereditary
epilepsy in humans (Gardiner, 1999, 2000). However, most mouse
mutations studied, and inherited epilepsies, predispose to seizure
in the absence of explicit challenge. This contrasts with BSP1/
neuropsin mutant animals that appear to be seizure-free in the
absence of inducer. There are exceptions, and spontaneous
seizure-free mutant mice have been reported in which the gene
disruption can either increase (Baraban et al., 1997; Furukawa et
al., 1997; Lu¨thi et al., 1997; Walz et al., 1999; Carrasco et al.,
2000) or decrease (Tsirka et al., 1995, 1997; Hamilton et al., 1997;
Liu et al., 1999; Jiang et al., 2000) seizure after a challenge.
Gene disruption, regional specificity, and
hippocampal function
The present work also contrasts significantly with these and many
transgenic studies in view of the effective regional specificity of
the gene disruption. Other family members, exemplified by t-PA,
are expressed widely in the nervous system. Brain expression of
BSP1/neuropsin is primarily restricted to the hippocampus and
amygdala (Chen et al., 1995; Davies et al., 1998). Thus the
observed phenotype may selectively reflect primary dysfunction
originating in limbic areas and not, for example, in the cortex and
other brain areas (but the activity of which may be subservient to
inputs from the hippocampus and amygdala).
Within the hippocampus itself, the failure of BSP1/neuropsin
gene disruption to affect either hippocampal LTP or spatial
navigation contrasts with the established roles of other family
members in these processes. Although a recent report using in
vivo administration of monoclonal antibodies or antisense oligo-
nucleotides to BSP1/neuropsin suggested that these experimental
manipulations reduce early phase LTP (Komai et al., 2000),
sustained potentiation was maintained, although at a slightly
Figure 6. Immediate early (c-fos) gene expression and
physiological response to kainic acid challenge. A, c-fos
mRNA expression revealed by in situ hybridization in
BSP1/neuropsin knock-out (/) animals (bottom) and
wild-type littermate controls (/; top). Example expres-
sion patterns are shown before (0) and 120 min after injec-
tion of kainic acid (15 mg/kg, i.p.); increased expression is
seen in BSP1/neuropsin knock-out mice. B, Survival of mice
after injection of kainic acid (30 mg/kg, i.p.). BSP1/neurop-
sin homozygous knock-out animals (/; dashed line; n 
8) display significant susceptibility compared with wild-type
littermate controls (/; solid line; n 10). C, c-fos mRNA
expression (in situ hybridization) in BSP1/neuropsin knock-
out (/) animals (bottom) and wild-type littermate con-
trols (/; top) at various time points (in minutes) after
injection of kainic acid (30 mg/kg, i.p.). Induction of in-
creased expression is demonstrated in BSP1/neuropsin mu-
tant animals at all time points.
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reduced level. At first sight these results appear to contradict
those of the present study. However, it was reported that low
concentrations of recombinant neuropsin facilitated LTP whereas
higher concentrations inhibited (Komai et al., 2000); this could
agree with the trend for a slight facilitation of LTP in BSP1/
neuropsin knock-out animals reported here.
Possible mechanism of BSP1/neuropsin action
The mechanism by which BSP1/neuropsin regulates epileptogenic
activity is not known. Polyspikes, such as those we observe in
BSP1/neuropsin mutant slices, have been ascribed to activity-
dependent disinhibition of excitatory synaptic transmission and
concurrent NMDA receptor activation and may provide a mea-
sure of inhibitory tone (Dingledine and Korn, 1985; Thompson
and Ga¨hwiler, 1989). BSP1/neuropsin could facilitate the efficacy
of inhibitory, predominantly GABAergic, afferents within the
hippocampus. A small but reproducible increase in paired-pulse
facilitation, without alteration in fEPSP or population spike am-
plitude, accords with this interpretation but does not exclude
other mechanisms, such as alterations in cellular processes con-
trolling glutamate release or postsynaptic glutamate receptor
function.
Although no gross morphological defects were noted in the
knock-out animals, high expression of BSP1/neuropsin through-
out development (Chen et al., 1998) could be compatible with a
role in determining the fine structural organization of brain
circuitry during embryogenesis. Formally, therefore, our studies
do not exclude the possibility that the observed phenotype might
be caused by a developmental abnormality rather than by an
absence of BSP1 expression in the adult.
A great diversity of ion channels and neurotransmitter recep-
tors have been implicated in the pathophysiology of epilepsy
(Frankel, 1999; Gardiner, 1999, 2000). The specific target for
BSP1/neuropsin remains to be established; indeed, BSP1/neurop-
sin may exert its effects via catalyzed cleavage of target proteins
that themselves regulate receptor/channel function. Although
some pathways of proteolytic regulation appear to operate intra-
cellularly (Bi et al., 1998), BSP1/neuropsin harbors a secretion
signal sequence and is more likely to act outside the cell. Extra-
cellular proteolysis is generally held to increase seizure activity,
as reported for trypsin, plasmin, and thrombin (Yamada and
Bilkey, 1993; Mizutani et al., 1996; Lee et al., 1997). Reported
modulation of GABA and NMDA channels by proteolytic activ-
ity (Mizutani et al., 1996; Gingrich et al., 2000) may operate,
indirectly, via a family of protease-activated receptors (PARs).
Although these are generally activated by thrombin, PAR-2 was
maximally activated by trypsin/tryptase-like proteases (for re-
view, see Gingrich and Traynelis, 2000). BSP1/neuropsin is of this
type and, in view of its abundance and restricted distribution, is
a strong candidate for a regulator of PAR-2 activation in the
hippocampus; PAR-2 activity in cultured hippocampal neurons
has been reported, but expression in vivo remains to be confirmed
(Smith-Swintosky et al., 1997).
Nevertheless, although it is often assumed that brain serine
proteases are required to be enzymatically active to exert their
effects, there are precedents for nonenzymatic regulation. For
instance, microglial activation by t-PA activation proceeds via a
nonproteolytic mechanism (Rogove et al., 1999), whereas t-PA-
mediated protection against zinc neurotoxicity is insensitive to
enzyme inhibition (Kim et al., 1999). It is possible that BSP1/
neuropsin acts by binding to specific receptor targets in the brain.
Further work will be required to establish the in vivo target(s) for
BSP1/neuropsin.
Whereas the mechanism of BSP1/neuropsin action remains to
be elucidated, the phenotype of the mutant animals confirms an
important role for this enzyme in vivo. Together, our data suggest
a role for BSP1/neuropsin in inhibiting neuronal excitability,
particularly under insult conditions. Reports that kindling and
oxidative stress cause an upregulation of BSP1/neuropsin mRNA
(Akita et al., 1997; Chen et al., 1998) may support this suggestion.
BSP1/neuropsin, seizure, and hippocampal control of
cortical activation
The properties of BSP1/neuropsin mutant mice may also illumi-
nate hippocampal control of cortical activity. Although BSP1/
neuropsin is expressed predominantly in the hippocampus, amyg-
dala, and adjoining brain regions (Chen et al., 1995; Davies et al.,
1998), kainate-induced neuronal hyperactivity (reflected in c-fos
expression) was seen throughout the brain of mutant animals.
This reiterates the pathophysiology of human epilepsy in which
focal discharges, originating commonly in the vicinity of the
hippocampus, lead to global brain activity (Gastaut, 1970) and
further emphasizes the limbic (and particularly hippocampal)
control of cortical activity that may underlie some aspects of
declarative memory encoding and recall (Squire et al., 1984).
Although our results suggest an important role for BSP1/
neuropsin under insult conditions, human epileptic seizures are
often precipitated by physiological and/or environmental stimuli
that are otherwise innocuous. We do not exclude the possibility
that BSP1/neuropsin might play a role in dampening the onset of
epileptiform activity under normal physiological conditions.
Spontaneous seizures were not noted in BSP1/neuropsin mutant
animals, but seizure activity can be difficult to detect, particularly
if it occurs rarely. Experiments with nonpharmacologic epilepto-
genic stimuli [including auditory stimuli (Ross and Coleman,
2000)] may be warranted. Because our results argue that BSP1/
neuropsin may regulate seizure activity, it remains to be investi-
gated whether pharmacologic agents modulating the activity of
hippocampal BSP1/neuropsin (or its substrates) might be of ther-
apeutic value in some forms of epilepsy.
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